C-model: A comprehensive enhanced pharmacokinetic/pharmacodynamic simulation environment targeting the complement...

Area of Science:

• Immunology
• Computational Biology
• Pharmacodynamics

Background:

• The complement system is crucial in numerous diseases, but treatment is challenging due to disease heterogeneity and varied responses.
• Understanding complement activation pathways and regulation is vital for effective disease management.

Purpose of the Study:

• To introduce C-model, a comprehensive computational environment for simulating the complement system.
• To address challenges in managing complement-related diseases through advanced modeling.

Main Methods:

• C-model simulates alternative, classical, and lectin complement activation pathways, plus the terminal/lytic pathway.
• The model incorporates fluid phase and cell-associated regulation (erythrocytes, endothelial cells).
• It integrates experimental patient data and simulated drug effects.

Main Results:

• C-model accurately forecasts complement biomarkers in healthy and diseased states.
• The model predicts patient responses to various therapeutic interventions.
• Simulation data is publicly available for academic research.

Conclusions:

• C-model is an advanced pharmacokinetic/pharmacodynamic tool supporting novel therapy development.
• It facilitates personalized patient management by enabling scenario simulations.
• The model enhances understanding of the complement system's role in disease.